At PCM Trials, I directed up to 11 concurrent global Phase I–IV and decentralized studies, managing delivery from start-up through closeout. I owned project plans, budgets, risks, and sponsor reporting.
I led the Pfizer Paxlovid program across 20+ countries and 300+ sites under compressed timelines, earning a 10/10 client satisfaction score and supporting a contract extension. I also managed 12 direct reports and oversaw vendors, sites, and cross-functional study teams.
At Prime Path MedTech, I built the regulatory and project-tracking structure used to manage document status, ownership, timelines, risks, and client deliverables. My clinical operations experience also includes pharmacovigilance programs, Phase I–IV research coordination, and regulated pharmaceutical operations.

